Human liver material in an assay does not make every result a clinical observation.
What the supplied paper shows
An avitinib study used rat and human liver microsomes and in-vivo rat probe experiments. Midazolam was among the tested substrates, and inhibitory signals varied across enzymes and experimental systems.
Limits of the finding
The work did not directly measure coadministration in human patients. Species, concentration, route and repeated-exposure differences constrain extrapolation, and a laboratory inhibition value is not an individual clinical interaction ratio.
What matters in a forensic review
Label each evidence stream clearly. A plausible CYP3A interaction can justify further assessment but cannot establish the magnitude of a patient’s exposure change. Review actual co-medications and measured concentrations before attributing an episode of sedation to the laboratory mechanism.
Source and related reading
Source: PMC8387736, supplied full-text paper. Findings are paraphrased; forensic implications are an interpretation.
Related: Unchanged Midazolam Exposure Does Not Establish Absence of Every Lemborexant Interaction.
Leave a Reply